First-trimester screening for fetal aneuploidy: Biochemistry and nuchal translucency

Ultrasound in Obstetrics and Gynecology

Volumn 10, Issue 6, 1997, Pages 381-386

  Orlandi, F ^a,c   Damiani, G ^a   Hallahan, T W ^b   Krantz, D A ^b   Macri, J N ^b  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b NTD Laboratories   (United States)

^c Centro di Diagnosi Prenatale   (Italy)

Author keywords

Down's syndrome; Free beta human chorionic gonadotropin; Nuchal translucency; Pregnancy associated plasma protein A; Prenatal screening

Indexed keywords

BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PROTEIN A;

ADULT; ANEUPLOIDY; ARTICLE; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN EXPERIMENT; MATERNAL AGE; MATERNAL BLOOD; NORMAL HUMAN; PRENATAL SCREENING; PRIORITY JOURNAL; TRIPLOIDY; TRISOMY 13; TRISOMY 18;

ADOLESCENT; ADULT; ANEUPLOIDY; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; FETAL DISEASES; HUMANS; MIDDLE AGED; NECK; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 0031438395     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0705.1997.10060381.x     Document Type: Article

References (14)

1. Krantz, D. A., Larsen, J. W., Buchanan, P. D. and Macri, J. N. (1996). First-trimester Down syndrome screening: free beta human chorionic gonadotropin and pregnancy-associated plasma protein A. Am. J. Obstet. Gynecol., 174, 612-16
2. Macri, J. N., Spencer, K., Aitken, D., Garver, K., Buchanan, P. D., Muller, F. and Boue, A. (1993). First trimester free beta (hCG) screening for Down syndrome. Prenat. Diagn., 13, 557-62
3. Berry, E., Aitken, D. A., Crossley, J. A., Macri, J. N. and Connor, M. J. (1995). Analysis of maternal serum alpha-feto-protein and free beta human chorionic gonadotropin in the first trimester: implications for Down's syndrome screening. Prenat. Diagn., 15, 555-65
4. Aitken, D. A., Mccaw, G., Crossley, J. A., Berry, E., Connor, J. M., Spencer, K. and Macri, J. N. (1993). First trimester biochemical screening for fetal chromosome abnormalities and neural tube defects. Prenat. Diagn., 13, 681-9
5. Wald, N. J., Kennard, A. and Hackshaw, A. K. (1995). First trimester serum screening for Down's syndrome. Prenat. Diagn., 15, 1227-40
6. Macintosh, McM. and Chard, T. (1993). Biochemical screening for Down's syndrome in the first trimester of pregnancy. Fetal Matern. Med. Rev., 5, 181-90
7. Brambati, B., Cislaghi, C., Tului, L., Alberti, E., Amidani, M., Columbo, U. and Zuliani, G. (1995). First trimester Down's syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling. Ultrasound Obstet. Gynecol., 5, 9-14
8. Szabo, J. and Gellen, J. (1990). Nuchal fluid accumulation in trisomy 21 detected by vaginography in first trimester. Lancet, 336, 1133
9. Macri, J. N., Anderson, R. W., Krantz, D. A., Larsen, J. W. and Buchanan, P. D. (1996). Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome. Am. J. Obstet. Gynecol., 174, 566-72
10. Nicolaides, K. H., Azar, G., Byrne, D., Mansur, C. and Marks, K. (1992). Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br. Med. J., 304, 867-9
11. Nicolaides, K. H., Brizot, M. L. and Snijders, R. J. M. (1994). Fetal nuchal translucency thickness: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br. J. Obstet. Gynaecol., 101, 782-6
12. Pandya, P. P., Snijders, R. J., Johnson, S. P., De-Lourdes-Brizot, M. and Nicolaides, K. H. (1995). Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br. J. Obstet. Gynaecol., 102, 957-62
13. Noble, P. L., Abraha, H. D., Snijders, R. J., Sherwood, R. and Nicolaides, K. H. (1995). Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness. Ultrasound Obstet. Gynecol., 6, 390-5
14. Brizot, M. L., Snijders, R. J. M., Butler, J., Bersinger, N. A. and Nicolaides, K. H. (1995). Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy. Br. J. Obstet. Gynaecol., 102, 127-32